US$ 26.02
gip and glp 1 receptor agonist Understand GLP-1/GIP Dual Tirzepatide Its Effect on Current Weight Loss Therapy Frontiers | The evolution of
Description
This pricing dynamic constrains overall market penetration and slows adoption despite the strong clinical benefits of GLP-1 therapies in weight management and glycemic control, making cost a key obstacle to broader global uptake

BMJ 25(385):e078242 Pokharel Y, Khariton Y, Tang Y, Nassif ME, Chan PS, Arnold SV et al (2017) Association of serial Kansas City Cardiomyopathy Questionnaire assessments with death and hospitalization in patients with heart failure with preserved and reduced ejection fraction: a secondary analysis of 2 randomized clinical trials

Effect of renal impairment on the pharmacokinetics of a single oral dose of danuglipron in participants with type 2 diabetes

The American Medical Association (AMA) reports that state-level spending on GLP-1s varies, reflecting these differences
